InvestSMART

Bio-Gene Technology Ltd (ASX:BGT)

ALERT: Price-sensitive ASX Announcement for BGT
Current share price for BGT : $0.017 -0.018 (-51.43%)+
Announcement
Release
16 Mar 2026 8:18AM
Price at Release
$0.035
Full Release
download
Summary
Bio-Gene Technology Ltd has entered into a partnership with Sumitomo Corporation and Nakashima Trading Co. to develop and market Qcide, a 100% natural insecticide, in Japan. The product targets household nuisance insect pests and is anticipated to launch in late 2026. Bio-Gene will supply the Qcide oil from Queensland, while Sumitomo will oversee trade logistics and Nakashima will handle the product's formulation and retail distribution. The project aligns with the growing market demand for natural insecticides in Japan, projected at US$1B annually. Qcide's OMRI listing supports its use in organic production.
Key Points
  • Bio-Gene Technology Ltd (BGT) partners with Sumitomo Corporation and Nakashima Trading Co. for Qcide® launch in Japan.
  • Qcide is a 100% natural insecticide developed by Bio-Gene from Eucalyptus cloeziana.
  • Target market is household nuisance insect pests in Japan, expected launch in late 2026.
  • Non-binding term sheet signed with definitive agreements expected by April/May 2026.
  • Bio-Gene to produce Qcide oil in Queensland, Australia.
  • Sumitomo to manage ordering, trade financing, transportation, and import approval.
  • Nakashima will handle formulation, packaging, promotion, and supply to retail.
  • Japanese home insecticide market is estimated at US$1B annually with growing demand for natural products.
  • Qcide is OMRI listed, approved for use in certified organic production.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.